Diagnosis and management of hyperbilirubinemia in the term neonate: For a safer first week

Pediatric Clinics of North America

Volumn 51, Issue 4, 2004, Pages 843-861

  Bhutani, Vinod K ^a   Johnson, Lois H ^a,b   Keren, Ron ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ACUTE DISEASE; BIOSAFETY; BRAIN DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; CONCENTRATION (PARAMETERS); DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EMERGENCY WARD; FAMILY; FOLLOW UP; GESTATION PERIOD; HEALTH PROGRAM; HEALTH STATUS; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INFANCY; INFANT; INTENSIVE CARE; JAUNDICE; KERNICTERUS; LACTATION; LONG TERM CARE; MATURITY; NEUROLOGIC DISEASE; NEUROTOXICITY; NEWBORN; NEWBORN DISEASE; NOMOGRAM; NUTRITION; ONSET AGE; OUTPATIENT CARE; PEER REVIEW; PERINATAL PERIOD; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMATURITY; PROPHYLAXIS; QUALITY CONTROL; REVIEW; SCREENING; TIME; TRANSFUSION; TREATMENT PLANNING; WELLBEING;

EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; KERNICTERUS; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 3242691714     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.03.011     Document Type: Review

References (23)

1. Brown A.K., Johnson L. Loss of concern about jaundice and the reemergence of KI in full-term infants in the era of managed care. Fanaroff A.A., Klaus M.H. The yearbook of neonatal and perinatal medicine. 1996;xvii-xxviii Mosby Yearbook, Philadelphia
2. Johnson L., Brown A.K., Bhutani V.K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 93:2002;488-494
3. Johnson L., Bhutani V.K. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol. 25(3):1998;555-574
4. Bhutani V.K., Johnson L., Sivieri E.M. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 103(1):1999;6-14
5. Bhutani V.K., Gourley G., Kreamer B.L., Dalin C., Adler S.A., Johnson L. Non-invasive measurement of total serum bilirubin in a multi-racial pre-discharge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 106(2):2000;e17
6. AAP Subcommittee on Neonatal Hyperbilirubinemia Neonatal jaundice and kernicterus. Pediatrics. 108:2001;763-765
7. Stevenson D.K., Fanaroff A., Maisels J., Young B.W., Wong R.J., Vreman H.J., et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics. 108:2001;31-39
8. Martinez J.C., Garcia H.O., Otheguy L.E., Drummond G.S., Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 103(1):1999;1-5
9. Johnson L. The hyperbilirubinemic term infant: when to worry, when to treat. N Y State J Med. 11:1991;483-488
10. Brown A.K., Damus K., Kim M.H., King K., Harper R., Campbell D., et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med. 27(4):1999;263-275
11. Bhutani V.K., Johnson L.H. Newborn jaundice and kernicterus health and societal perspectives. Indian J Pediatr. 70(5):2003;407-416
12. Bhutani V.K., Johnson L.H. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns. J Perinatal. 21(Suppl 1):2001;S76-S82
13. American Academy of Pediatrics practice parameter Management of hyperbilirubinemia in the healthy term newborns. Pediatrics. 94:1994;558-565
14. Kaplan M., Hammerman C., Feldman R., Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 105:2000;533-537
15. van Pragh R. Diagnosis of kernicterus in the neonatal period. Pediatrics. 28:1961;870-874
16. Volpe J.J. Bilirubin and brain injury. Volpe J.J. Neurology of the newborn. 4th Edition:2001;521-546 WB Saunders, Philadelphia
17. Johnson L., Brown A.K., Bhutani V.K. BIND - a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics. 104(Suppl):1999;746
18. Newman T.B., Xiong B., Gonzales V.M., Escobar G.J. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 154:2000;1140-1147
19. Ip S., Glicken S., Kulig J., Obrien R., Sege R., Lau J. Management of neonatal hyperbilirubinemia. 2003;US Department of Health and Human Services, Agency for Healthcare Reserach and Quality, Rockville, MD. AHRQ Publication 03, E011. Available at http://www.ahrq.gov/kernicterus. Accessed June 17, 2004
20. Dennery P.A., Seidman D., Stevenson D.K. Neonatal hyperbilirubinemia. N Engl J Med. 334:2001;581-590
21. Alcock G.S., Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev. (3):2002;CD003313
22. Newman T.B., Klebanoff M. Neonatal hyperbilirubinemia and long-term outcome: another look at the collaborative perinatal project. Pediatrics. 92:1993;651-657
23. Valaes T. Problems with prediction of neonatal hyperbilirubinemia. Pediatrics. 108:2001;175-177